Urgent.News

What's breaking now, across thousands of outlets.

Business

Sales slump at UK’s largest brickmaker as housebuilding downturn deepens

Ibstock, which has cut production by a fifth, criticises government for delay in help for housing sector Sales at the UK’s largest brickmaker plunged by more than a fifth over the summer, as it criticised the government for not introducing fresh help for the housing sector faster. Leicestershire-based Ibstock said on Monday that sales slumped by 22% below its expectations in the three months to…

Sales slump at UK’s largest brickmaker as housebuilding downturn deepens

UK's largest brickmaker, Ibstock, is experiencing a significant sales slump as the housebuilding sector continues to struggle. The company has reported a 22% drop in sales, far below its expectations, leading to a decision to slash production levels by a fifth. Ibstock's chief executive, Joe Hudson, stated that trading conditions deteriorated sharply during the third quarter, with weakness persisting into October.

The company, which expects full-year profits to be "materially below" previous forecasts, has issued its second profit warning of the year. This comes days after the Office for Budget Responsibility reduced its forecast for the number of new homes built by 2031 by 190,000, casting doubt on the government's goal of constructing 1.5 million new homes during the current parliament.

Ibstock has criticized the government for the delay in introducing a support scheme aimed at helping first-time buyers in England purchase a newbuild home with a 2.5% deposit. The company expects full-year profits to be in the mid-£40m range, a significant drop from the previous consensus of £59m. Analysts at Peel Hunt noted that domestically exposed building stocks like Ibstock continue to face challenging industry conditions, with the introduction of the Your First Home support scheme providing some potential relief, but lower interest rates remaining crucial for a rebound in sector activity and share prices.

Written by urgent.news from Guardian Business's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at theguardian.com →

More in Business

Samsung Biologics Secures Nearly 98% Stake in PolyPeptide

Samsung Biologics announced on Nov. 2 that it recorded a final subscribed stake of 97.98% in the tender offer for the global peptide contract development and manufacturing organization (CDMO) company…

  • Samsung Biologics acquired nearly 98% of PolyPeptide Group on November 2.
  • The transaction met the compulsory purchase threshold for minority shares.
  • Deal valued at 1.46 billion Swiss francs, expanding Samsung Biologics' peptide business.

Broadcom Loses Supreme Court Appeal with Pressure on Samsung

U.S. semiconductor company Broadcom has finally lost a lawsuit filed to cancel the penalty surcharge imposed by the Fair Trade Commission for forcing a long-term agreement on Samsung…

  • Broadcom semiconductor company loses Supreme Court appeal.
  • Fair Trade Commission imposed $14M surcharge on Samsung.
  • Case revolved around Broadcom's demand for Samsung contract.

More from Monday 2 November →